Abnormal Liver Function Tests in Patients With COVID‐19: Relevance and Potential Pathogenesis
Anna Bertolini(University Medical Center Groningen), Giulia Peserico(Istituto Oncologico Veneto), Henkjan J. Verkade(University Medical Center Groningen), Mario Strazzabosco(Smilow Cancer Hospital), Fabio Farinati(University of Padua), Ivo P. van de Peppel(University Medical Center Groningen), Frank A.J.A. Bodewes(University Medical Center Groningen), Alberto Fantin(Istituto Oncologico Veneto), Romina Fiorotto(Yale University), Han Moshage(University Medical Center Groningen), Johan W. Jonker(University Medical Center Groningen)
Cited by 302
Related Papers
Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances
|Hepatology|2018|340
Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma
|Journal of Hepatology|2018|187
Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept
|The Lancet Oncology|2023|184